Literature DB >> 29598900

Small-molecules that bind to the ubiquitin-binding motif of REV1 inhibit REV1 interaction with K164-monoubiquitinated PCNA and suppress DNA damage tolerance.

Murugendra Vanarotti1, Benjamin J Evison1, Marcelo L Actis1, Akira Inoue1, Ezelle T McDonald1, Youming Shao2, Richard J Heath2, Naoaki Fujii3.   

Abstract

REV1 protein is a mutagenic DNA damage tolerance (DDT) mediator and encodes two ubiquitin-binding motifs (i.e., UBM1 and UBM2) that are essential for the DDT function. REV1 interacts with K164-monoubiquitinated PCNA (UbPCNA) in cells upon DNA-damaging stress. By using AlphaScreen assays to detect inhibition of REV1 and UbPCNA protein interactions along with an NMR-based strategy, we identified small-molecule compounds that inhibit the REV1/UbPCNA interaction and that directly bind to REV1 UBM2. In cells, one of the compound prevented recruitment of REV1 to PCNA foci on chromatin upon cisplatin treatment, delayed removal of UV-induced cyclopyrimidine dimers from nuclei, prevented UV-induced mutation of HPRT gene, and diminished clonogenic survival of cells that were challenged by cyclophosphamide or cisplatin. This study demonstrates the potential utility of a small-molecule REV1 UBM2 inhibitor for preventing DDT.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  PCNA; Protein-protein interaction; REV1; Small-molecule; Ubiquitin-binding motif

Mesh:

Substances:

Year:  2018        PMID: 29598900      PMCID: PMC5935547          DOI: 10.1016/j.bmc.2018.03.028

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  33 in total

1.  Structural analysis of the conserved ubiquitin-binding motifs (UBMs) of the translesion polymerase iota in complex with ubiquitin.

Authors:  Daniel Burschowsky; Fabian Rudolf; Gwénaël Rabut; Torsten Herrmann; Matthias Peter; Peter Matthias; Gerhard Wider
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

Review 2.  Translesion DNA synthesis polymerases in DNA interstrand crosslink repair.

Authors:  The Vinh Ho; Orlando D Schärer
Journal:  Environ Mol Mutagen       Date:  2010-07       Impact factor: 3.216

Review 3.  Cellular functions of DNA polymerase zeta and Rev1 protein.

Authors:  Christopher W Lawrence
Journal:  Adv Protein Chem       Date:  2004

4.  Screening for inhibitors of low-affinity epigenetic peptide-protein interactions: an AlphaScreen-based assay for antagonists of methyl-lysine binding proteins.

Authors:  Tim J Wigle; J Martin Herold; Guillermo A Senisterra; Masoud Vedadi; Dmitri B Kireev; Cheryl H Arrowsmith; Stephen V Frye; William P Janzen
Journal:  J Biomol Screen       Date:  2009-12-11

5.  Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.

Authors:  J Kevin Hicks; Colleen L Chute; Michelle T Paulsen; Ryan L Ragland; Niall G Howlett; Quentin Guéranger; Thomas W Glover; Christine E Canman
Journal:  Mol Cell Biol       Date:  2009-12-22       Impact factor: 4.272

6.  Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system.

Authors:  D S Garrett; Y J Seok; A Peterkofsky; G M Clore; A M Gronenborn
Journal:  Biochemistry       Date:  1997-04-15       Impact factor: 3.162

7.  Error-prone translesion synthesis mediates acquired chemoresistance.

Authors:  Kun Xie; Jason Doles; Michael T Hemann; Graham C Walker
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-10       Impact factor: 11.205

8.  Identification of the first small-molecule inhibitor of the REV7 DNA repair protein interaction.

Authors:  Marcelo L Actis; Nigus D Ambaye; Benjamin J Evison; Youming Shao; Murugendra Vanarotti; Akira Inoue; Ezelle T McDonald; Sotaro Kikuchi; Richard Heath; Kodai Hara; Hiroshi Hashimoto; Naoaki Fujii
Journal:  Bioorg Med Chem       Date:  2016-07-16       Impact factor: 3.641

Review 9.  DNA repair pathways as targets for cancer therapy.

Authors:  Thomas Helleday; Eva Petermann; Cecilia Lundin; Ben Hodgson; Ricky A Sharma
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

10.  Overexpression of Rev1 promotes the development of carcinogen-induced intestinal adenomas via accumulation of point mutation and suppression of apoptosis proportionally to the Rev1 expression level.

Authors:  Megumi Sasatani; Yang Xi; Junko Kajimura; Toshiyuki Kawamura; Jinlian Piao; Yuji Masuda; Hiroaki Honda; Kei Kubo; Takahiro Mikamoto; Hiromitsu Watanabe; Yanbin Xu; Hidehiko Kawai; Tsutomu Shimura; Asao Noda; Kanya Hamasaki; Yoichiro Kusunoki; Elena Karamfilova Zaharieva; Kenji Kamiya
Journal:  Carcinogenesis       Date:  2017-05-01       Impact factor: 4.944

View more
  8 in total

1.  A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.

Authors:  Jessica L Wojtaszek; Nimrat Chatterjee; Javaria Najeeb; Azucena Ramos; Minhee Lee; Ke Bian; Jenny Y Xue; Benjamin A Fenton; Hyeri Park; Deyu Li; Michael T Hemann; Jiyong Hong; Graham C Walker; Pei Zhou
Journal:  Cell       Date:  2019-06-06       Impact factor: 41.582

2.  Sml1 Inhibits the DNA Repair Activity of Rev1 in Saccharomyces cerevisiae during Oxidative Stress.

Authors:  Rui Yao; Pei Zhou; Chengjin Wu; Liming Liu; Jing Wu
Journal:  Appl Environ Microbiol       Date:  2020-03-18       Impact factor: 4.792

Review 3.  The Rev1-Polζ translesion synthesis mutasome: Structure, interactions and inhibition.

Authors:  Alessandro A Rizzo; Dmitry M Korzhnev
Journal:  Enzymes       Date:  2019-08-09

Review 4.  DNA damage tolerance in stem cells, ageing, mutagenesis, disease and cancer therapy.

Authors:  Bas Pilzecker; Olimpia Alessandra Buoninfante; Heinz Jacobs
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

Review 5.  DNA Damage Tolerance Pathways in Human Cells: A Potential Therapeutic Target.

Authors:  Ashlynn Ai Li Ler; Michael P Carty
Journal:  Front Oncol       Date:  2022-02-07       Impact factor: 6.244

Review 6.  CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication.

Authors:  Sabrina Florencia Mansilla; María Belén de la Vega; Nicolás Luis Calzetta; Sebastián Omar Siri; Vanesa Gottifredi
Journal:  Genes (Basel)       Date:  2020-05-28       Impact factor: 4.096

Review 7.  Protein-Protein Interactions in Translesion Synthesis.

Authors:  Radha Charan Dash; Kyle Hadden
Journal:  Molecules       Date:  2021-09-13       Impact factor: 4.411

Review 8.  Translesion synthesis inhibitors as a new class of cancer chemotherapeutics.

Authors:  Seema M Patel; Radha Charan Dash; M Kyle Hadden
Journal:  Expert Opin Investig Drugs       Date:  2020-12-03       Impact factor: 6.206

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.